Browsing 01 University of Plymouth Research Outputs by Subject "Zoledronic Acid"

Now showing items 1-1 of 1

Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).

Andronis, L; Goranitis, I; Pirrie, S; Pope, A; Barton, D; Collins, S; Daunton, A; McLaren, D; O'Sullivan, JM; Parker, C; Porfiri, E; Staffurth, J; Stanley, A; Wylie, J; Beesley, S; Birtle, A; Brown, JE; Chakraborti, P; Hussain, SA; Russell, JM; Billingham, LJ; James, ND (England, 2017-04)

OBJECTIVE: To evaluate the cost-effectiveness of adding zoledronic acid or strontium-89 to standard docetaxel chemotherapy for patients with castrate-refractory prostate cancer (CRPC). PATIENTS AND METHODS: Data on resource ...